title: Clinical inquiries. Are DMARDs effective for rheumatologic diseases besides rheumatoid arthritis?
authors.affiliation: Eglin Air Force Base Family Medicine Residency, Eglin Air Force Base, FL, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: Goodemote
authors.forename: Barbara
authors.initials: B
authors.lastname: Jamieson
authors.forename: Richard
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000150:complications / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D005050:Etretinate / Q000627:therapeutic use; D006801:Humans; D000069285:Infliximab; D007592:Joint Diseases / Q000209:etiology; D008727:Methotrexate / Q000627:therapeutic use; D009260:Nail Diseases / Q000209:etiology; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D012460:Sulfasalazine / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D012460:Sulfasalazine; D005050:Etretinate; D000069285:Infliximab; D001379:Azathioprine; D008727:Methotrexate